RadioBDC Logo
Sail | AWOLNATION Listen Live
THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Baxter says EU clears avian flu vaccine Vepacel

March 2, 2012
Text size +
  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.

DEERFIELD, Ill.—European Union regulators approved Baxter International Inc.'s avian flu vaccine Vepacel, the drugmaker said Friday.

Vepacel is approved for use in adults 18 and older, including people with weak immune systems and people who are chronically ill, the company said. The vaccine is intended to protect patients against emerging flu strains before a pandemic is officially declared.

The approval allows Baxter to market Vepacel in all European Union member countries as well as Iceland, Norway, and Liechtenstein, the company said.

Shares of Baxter International fell 15 cents to $58.15 in morning trading. Its shares have traded in a 52-week range of $47.55 to $62.50.

  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.